Cascade Investment Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Buy
21,265
+7,690
+57% +$724K 0.83% 54
2026
Q1
$1.6M Buy
13,575
+1,660
+14% +$205K 0.95% 46
2025
Q4
$1.5M Buy
+11,915
New +$1.55M 0.88% 50
2023
Q2
Sell
-35
Closed -$5.83K 244
2023
Q1
$5.83K Buy
+35
New +$5.74K ﹤0.01% 221
2022
Q3
Sell
-35
Closed -$6.02K 239
2022
Q2
$6.02K Hold
35
﹤0.01% 228
2022
Q1
$6.6K Buy
+35
New +$6.92K ﹤0.01% 245

Other funds holding ZTS

Cascade Investment Advisors's ZTS Position: Q2 2026 in Review

Cascade Investment Advisors increased its Zoetis (ZTS) stake by 57% in Q2 2026, buying an estimated $724K and bringing the position to 21,265 shares worth $1.53M. The position accounts for 0.83% of the portfolio, ranked #54.

Cascade Investment Advisors first reported a position in ZTS in Q1 2022 and has held it in 6 quarters since. The position peaked at $1.6M in Q1 2026. 271 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Cascade Investment Advisors held 21,265 shares of Zoetis worth $1.53M as of Q2 2026.
  • Cascade Investment Advisors bought 7,690 Zoetis shares in Q2 2026, an estimated $724K.
  • Zoetis made up 0.83% of Cascade Investment Advisors's portfolio in Q2 2026, its #54 holding.
  • Cascade Investment Advisors first reported a position in Zoetis in Q1 2022 and has held it in 6 quarters since.
  • Cascade Investment Advisors's Zoetis position peaked at $1.6M in Q1 2026.
  • 271 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Cascade Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.